menu
    • menu

    Company profile for AC Immune

    NEW Drugs in Dev: 10
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AC Immune’s leadership team combines a proven track record in entrepreneurial management and world-class scientific thought leadership. The team is committed to excellence and is passionate about delivering breakthrough therapies for neurodegenerative diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AC ImmuneSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    EPFL Innovation Park Building B 1015 Lausanne
    Telephone
    Telephone
    +41 21 345 91 21
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.acimmune.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AC Immune Gets Goradia Grant for ACI-7104 Parkinson's Disease
    AC Immune Gets Goradia Grant for ACI-7104 Parkinson's Disease

    11 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/11/3310336/0/en/ac-immune-to-receive-research-grant-from-goradia-family-for-development-of-aci-7104-in-parkinson-s-disease.html

    GLOBENEWSWIRE
    11 Jun 2026
    Share Share
    AC Immune Presents Phase 1 Data on TDP-43 PET Tracer ACI-19626
    AC Immune Presents Phase 1 Data on TDP-43 PET Tracer ACI-19626

    22 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/22/3300024/0/en/ac-immune-presents-new-phase-1-data-indicating-higher-uptake-of-tdp-43-pet-tracer-aci-19626-in-patients-with-als.html

    GLOBENEWSWIRE
    22 May 2026
    Share Share
    AC Immune Starts Last Cohort In Phase 1B/2 ABATE Trial
    AC Immune Starts Last Cohort In Phase 1B/2 ABATE Trial

    30 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/30/3284675/0/en/ac-immune-initiates-final-cohort-in-ongoing-phase-1b-2-abate-trial-of-anti-abeta-active-immunotherapy-to-treat-alzheimer-s-disease.html

    GLOBENEWSWIRE
    30 Apr 2026
    Share Share
    AC Immune First Quarter 2026 Financial And Corporate Updates
    AC Immune First Quarter 2026 Financial And Corporate Updates

    30 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/30/3284706/0/en/ac-immune-first-quarter-2026-financial-and-corporate-updates.html

    GLOBENEWSWIRE
    30 Apr 2026
    Share Share
    AC Immune Revises Morphomer Tau Deal With Lilly
    AC Immune Revises Morphomer Tau Deal With Lilly

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3268952/0/en/AC-Immune-Announces-Amendment-to-Morphomer-Tau-License-and-Collaboration-Agreement-with-Lilly.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    Lilly Pays AC Immune $12.5M To Expand Alzheimer's Collab
    Lilly Pays AC Immune $12.5M To Expand Alzheimer's Collab

    07 Apr 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/lilly-pays-ac-immune-125m-expand-alzheimers-collab-small-molecule-draws-closer-clinic

    FIERCE BIOTECH
    07 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search